Valeant Pharmaceuticals International, Inc. 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Dec 17, 2013
Insider Transaction Report
Form 4
Pearson J. Michael
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock, no par value
2013-12-14$81.41/sh+184,247$14,999,548→ 4,025,498 total
Footnotes (1)
- [F1]This number represents the amount of shares purchased through a private transaction.